Hyperon,
PTD is dishing out around 67.5m shares to EGX holders plus 15c per share.
Using your value for the company (about $260m including DCF of earnings plus current cash);
164m + 67.5m = 231.5m shares
$260m / 231.5m shares = $1.12
Minus the 15c extra per share = about $1.00.
This is valuing EGX and current pipeline at $0. But of course, they are not worth nothing.
I believe $1.00 should be about the base price. I reckon it will keep heading this way until some good news comes out.
Same old problem with biotechs; how do you value potential??
I will probably think about getting in at $1.20 - $1.30. This is based on simple calculation of diluting the pre-takeover hype price for both and diluting it by the number of shares on issue. In other words, I am assuming the old price a few months ago was fair enough for the market so it might be fair enough again. I also thick 20-30c is fair value for their intellectual property given what they sold domantis for.
Risky stuff.
whatdaya yeckon?
- Forums
- ASX - By Stock
- PTD
- heading lower
PTD
unknown
heading lower, page-3
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)